PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DOCS vs. SWAV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


DOCSSWAV

Fundamentals


DOCSSWAV
Market Cap$10.84B$12.57B
EPS$0.87$4.25
PE Ratio66.7278.76
Total Revenue (TTM)$516.85M$421.78M
Gross Profit (TTM)$464.87M$368.26M
EBITDA (TTM)$207.68M$103.71M

Correlation

-0.50.00.51.00.3

The correlation between DOCS and SWAV is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

DOCS vs. SWAV - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%JuneJulyAugustSeptemberOctoberNovember
85.65%
1.40%
DOCS
SWAV

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DOCS vs. SWAV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Doximity, Inc. (DOCS) and ShockWave Medical, Inc. (SWAV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DOCS
Sharpe ratio
The chart of Sharpe ratio for DOCS, currently valued at 1.64, compared to the broader market-4.00-2.000.002.004.001.64
Sortino ratio
The chart of Sortino ratio for DOCS, currently valued at 3.68, compared to the broader market-4.00-2.000.002.004.006.003.68
Omega ratio
The chart of Omega ratio for DOCS, currently valued at 1.46, compared to the broader market0.501.001.502.001.46
Calmar ratio
The chart of Calmar ratio for DOCS, currently valued at 1.35, compared to the broader market0.002.004.006.001.35
Martin ratio
The chart of Martin ratio for DOCS, currently valued at 9.42, compared to the broader market0.0010.0020.0030.009.42
SWAV
Sharpe ratio
The chart of Sharpe ratio for SWAV, currently valued at 3.69, compared to the broader market-4.00-2.000.002.004.003.69
Sortino ratio
The chart of Sortino ratio for SWAV, currently valued at 6.48, compared to the broader market-4.00-2.000.002.004.006.006.48
Omega ratio
The chart of Omega ratio for SWAV, currently valued at 2.20, compared to the broader market0.501.001.502.002.20
Calmar ratio
The chart of Calmar ratio for SWAV, currently valued at 2.00, compared to the broader market0.002.004.006.002.00
Martin ratio
The chart of Martin ratio for SWAV, currently valued at 63.12, compared to the broader market0.0010.0020.0030.0063.12

DOCS vs. SWAV - Sharpe Ratio Comparison


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
1.64
3.69
DOCS
SWAV

Dividends

DOCS vs. SWAV - Dividend Comparison

Neither DOCS nor SWAV has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DOCS vs. SWAV - Drawdown Comparison


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-48.99%
-0.02%
DOCS
SWAV

Volatility

DOCS vs. SWAV - Volatility Comparison

Doximity, Inc. (DOCS) has a higher volatility of 33.04% compared to ShockWave Medical, Inc. (SWAV) at 0.00%. This indicates that DOCS's price experiences larger fluctuations and is considered to be riskier than SWAV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%JuneJulyAugustSeptemberOctoberNovember
33.04%
0
DOCS
SWAV

Financials

DOCS vs. SWAV - Financials Comparison

This section allows you to compare key financial metrics between Doximity, Inc. and ShockWave Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items